CLINICAL TRIALS – PHASE I & IIA First-in-human study design of VY1706, a systemically administered blood-brain barrier ...
Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation therapeutics for difficult-to-treat cancers, today announced a late-breaking oral presentation on micvotabart ...
Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation therapeutics for difficult-to-treat cancers, today announced a late-breaking oral presentation on micvotabart pelidotin (MICVO) ...
Multiple Posters Highlight the Breadth of Company’s Novel Genetic Medicine and Cell Therapy PlatformsLONDON and NEW YORK, Oct. 27, 2026 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a ...
CAMBRIDGE, CAMBRIDGESHIRE, UNITED KINGDOM, October 27, 2026 /EINPresswire.com/ -- ViaNautis Bio to present “polyNaut: ...
Prime Minister Narendra Modi inaugrated the Emerging Science, Technology and Innovation Conclave (ESTIC) 2026 at Bharat ...
Maddock Films has officially announced the trailer release date of EETHA, the upcoming musical drama starring Shraddha Kapoor ...
Hengrui Oncology has participated in the ESMO Congress for 11 consecutive years, beginning in 2016. Since 2023, the company has presented nearly 200 research findings at the congress, demonstrating ...
The 7th National Big Data Health Science Conference in Columbia, South Carolina, drew more than 200 participants from 17 ...
The Centre for Integrative Biology and Systems Medicine at IIT Madras is set to host a three-day international symposium on ...
VnExpress International on MSN
Over 40 studies explore digital and green transformation at BUV international conference
British University Vietnam hosted an international conference featuring 43 research presentations on AI, ESG reporting and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results